These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

290 related articles for article (PubMed ID: 9623918)

  • 1. Detection of HIV-Gag p24-specific antibodies in sera and saliva of HIV-1-infected adults and in sera of infants born to HIV-1-infected mothers.
    Yasuda S; Iwasaki M; Oka S; Naganawa S; Nakasone T; Honda M; Sata T; Kojima A; Matsuda S; Takemori T; Tsunetsugu-Yokota Y
    Microbiol Immunol; 1998; 42(4):305-11. PubMed ID: 9623918
    [TBL] [Abstract][Full Text] [Related]  

  • 2. IgA immunity in HIV type 1-infected chimpanzees. II. Mucosal immunity.
    Black KP; Fultz PN; Girard M; Jackson S
    AIDS Res Hum Retroviruses; 1997 Oct; 13(15):1273-82. PubMed ID: 9339844
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Characteristics of IgA antibodies against HIV-1 in sera and saliva from HIV-seropositive individuals in different clinical stages.
    Matsuda S; Oka S; Honda M; Takebe Y; Takemori T
    Scand J Immunol; 1993 Nov; 38(5):428-34. PubMed ID: 8235446
    [TBL] [Abstract][Full Text] [Related]  

  • 4. IgA immunity in HIV type 1-infected chimpanzees. I. Systemic immunity.
    Black KP; Fultz PN; Girard M; Jackson S
    AIDS Res Hum Retroviruses; 1997 Oct; 13(15):1263-72. PubMed ID: 9339843
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of the distribution of IgG and IgA antibodies in serum and various mucosal fluids of HIV type 1-infected subjects.
    Raux M; Finkielsztejn L; Salmon-Céron D; Bouchez H; Excler JL; Dulioust E; Grouin JM; Sicard D; Blondeau C
    AIDS Res Hum Retroviruses; 1999 Oct; 15(15):1365-76. PubMed ID: 10515152
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Variation of secretory antibodies in parotid saliva to human immunodeficiency virus type 1 with HIV-1 disease stage.
    Sun D; Archibald DW; Furth PA
    AIDS Res Hum Retroviruses; 1990 Jul; 6(7):933-41. PubMed ID: 2117957
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immunoblotting analysis of IgA and IgM antibody to human immunodeficiency virus type 1 (HIV-1) polypeptides in seropositive infants.
    Re MC; Furlini G; Vignoli M; Zauli G; Dallacasa P; Masi M; La Placa M
    Eur J Clin Microbiol Infect Dis; 1992 Jan; 11(1):27-32. PubMed ID: 1563380
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Development and standardization of methods to evaluate the antibody response to an HIV-1 candidate vaccine in secretions and sera of seronegative vaccine recipients.
    Raux M; Finkielsztejn L; Salmon-Céron D; Bouchez H; Excler JL; Dulioust E; Grouin JM; Sicard D; Blondeau C
    J Immunol Methods; 1999 Jan; 222(1-2):111-24. PubMed ID: 10022378
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Quantification of IgA and IgG and specificities of antibodies to viral proteins in parotid saliva at different stages of HIV-1 infection.
    Cartry O; Moja P; Quesnel A; Pozzetto B; Lucht FR; Genin C
    Clin Exp Immunol; 1997 Jul; 109(1):47-53. PubMed ID: 9218823
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Paucity of antigen-specific IgA responses in sera and external secretions of HIV-type 1-infected individuals.
    Mestecky J; Jackson S; Moldoveanu Z; Nesbit LR; Kulhavy R; Prince SJ; Sabbaj S; Mulligan MJ; Goepfert PA
    AIDS Res Hum Retroviruses; 2004 Sep; 20(9):972-88. PubMed ID: 15585085
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antibodies to recombinant gp160 in mucosal secretions and sera of persons infected with HIV-1 and seronegative vaccine recipients.
    Funkhouser A; Clements ML; Slome S; Clayman B; Viscidi R
    AIDS Res Hum Retroviruses; 1993 Jul; 9(7):627-32. PubMed ID: 8369168
    [TBL] [Abstract][Full Text] [Related]  

  • 12. More reliable diagnosis of infection with human immunodeficiency virus type 1 (HIV-1) by detection of antibody IgGs to pol and gag proteins of HIV-1 and p24 antigen of HIV-1 in urine, saliva, and/or serum with highly sensitive and specific enzyme immunoassay (immune complex transfer enzyme immunoassay): a review.
    Hashida S; Hashinaka K; Ishikawa S; Ishikawa E
    J Clin Lab Anal; 1997; 11(5):267-86. PubMed ID: 9292394
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Early detection of IgA specific antibodies in HIV-1 infected children by peptide-ELISA and peptide time-resolved fluoro-immunoassay.
    Lombardi V; Caniglia M; Scarlatti G; Jansson M; Plebani A; D'Argenio P; Scaccia S; Wigzell H; Rossi P
    Eur J Pediatr; 1993 Jun; 152(6):484-9. PubMed ID: 8335015
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Patterns of anti-HIV IgG3, IgA and p24Ag in perinatally HIV-1 infected infants.
    Louisirirotchanakul S; Kanoksinsombat C; Likanonsakul S; Sunthornkachit R; Supanit I; Wasi C
    Asian Pac J Allergy Immunol; 2002 Jun; 20(2):99-104. PubMed ID: 12403194
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Local synthesis of IgG antibodies to HIV within the female and male genital tracts during asymptomatic and pre-AIDS stages of HIV infection.
    Bélec L; Tévi-Bénissan C; Lu XS; Prazuck T; Pillot J
    AIDS Res Hum Retroviruses; 1995 Jun; 11(6):719-29. PubMed ID: 7576932
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Detection of salivary immunoglobulin A antibodies to HIV-1 in infants and children.
    Archibald DW; Johnson JP; Nair P; Alger LS; Hebert CA; Davis E; Hines SE
    AIDS; 1990 May; 4(5):417-20. PubMed ID: 2196908
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Salivary and mucosal immune responses to HIV and its co-pathogens.
    Challacombe SJ; Sweet SP
    Oral Dis; 1997 May; 3 Suppl 1():S79-84. PubMed ID: 9456663
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The affinity of IgG antibodies to gag p24 and p17 in HIV-1-infected patients correlates with disease progression.
    Chargelegue D; Stanley CM; O'Toole CM; Colvin BT; Steward MW
    Clin Exp Immunol; 1995 Feb; 99(2):175-81. PubMed ID: 7851008
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Neutralization of human immunodeficiency virus type 1 (HIV-1) mediated by parotid IgA of HIV-1-infected patients.
    Moja P; Tranchat C; Tchou I; Pozzetto B; Lucht F; Desgranges C; Genin C
    J Infect Dis; 2000 May; 181(5):1607-13. PubMed ID: 10823760
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Salivary IgA and serum IgA and IgG antibodies to Candida albicans in HIV-infected subjects.
    Belazi M; Fleva A; Drakoulakos D; Panayiotidou D
    Int J STD AIDS; 2002 Jun; 13(6):373-7. PubMed ID: 12015010
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.